Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 177

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Pain and Multiple Sclerosis: Pathophysiology and Treatment

Solaro, Claudio, Trabucco, Erika, Messmer Uccelli, Michele · 2013 · Current Neurology and Neuroscience Reports

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11910-012-0320-5

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 88

  1. Paty DW, Ebers GC. Multiple sclerosis 135–191. Philadelphia: F.A. Davis Company; 1999. p. 135–91.
  2. Brichetto G, Messmer Uccelli M, Mancardi GL, Solaro C. Symptomatic medication use in multiple sclerosis. Mult Scler. 2003;9(5):458–60. · DOI
  3. "Part III: pain terms, a current list with definitions and notes on usage" (pp 209–214) Classification of chronic pain, second edition, IASP Task Force on Taxonomy, edited by H. Merskey and N. Bogduk, IASP Press, Seattle; 1994. p. 209–14.
  4. Treede RD, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630–5. · DOI
  5. O’Connor AB, Schwid SR, Herrmann DN, Markman JD, Dworkin RH. Pain associated with multiple sclerosis: systematic review and proposed classification. Pain. 2008;137:96–111. · DOI · Paper page
  6. Clifford DB, Trotter JL. Pain in multiple sclerosis. Arch Neurol. 1984;41:1270–2. · DOI · Paper page
  7. Vermote R, Ketalaer P, Carltonn H. Pain in multiple sclerosis patients: a prospective study using the McGill pain questionnaire. Clin Neurol Neurosurg. 1986;88:87–93. · DOI
  8. Kassirer MR, Osterberg DH. Pain in chronic multiple sclerosis. J Pain Symptom Manage. 1987;2:95–7. · DOI
  9. Moulin DE, Foley KM, Ebers GC. Pain syndromes in multiple sclerosis. Neurology. 1988;38:1830–4. · DOI · Paper page
  10. Stenager E, Knutsen L, Jensen K. Acute and chronic pain syndromes in multiple sclerosis. Acta Neurol Scand. 1991;84:197–200. · DOI · Paper page
  11. Warnell P. The pain experience of a multiple sclerosis population: a descriptive study. Axon. 1991;13:26–8.
  12. Archibald CJ, et al. Pain prevalence, severity and impact in a clinical sample of multiple sclerosis patients. Pain. 1994;58:89–93. · DOI · Paper page
  13. Indaco A, Iachetta C, Nappi C, Socci L, Carrieri PB. Chronic and acute pain syndromes in patients with multiple sclerosis. Acta Neurol. 1994;16:97–102.
  14. Stenager E, Knudsen L, Jensen K. Acute and chronic pain syndromes in multiple sclerosis. Ital J Neurol Sci. 1995;16:629–32. · DOI
  15. Beiske AG, Pedersen ED, Czujko B, Myhr KM. Pain and sensory complaints in multiple sclerosis. Eur J Neurol. 2004;1:479–82. · DOI
  16. Ehde DM, et al. Chronic pain in a large community sample of persons with multiple sclerosis. Mult Scler. 2003;6:605–11. · DOI · Paper page
  17. Svendsen KB, et al. Pain in patients with multiple sclerosis: a population-based study. Arch Neurol. 2003;60:1089–94. · DOI · Paper page
  18. Solaro C, et al. The prevalence of pain in multiple sclerosis. A multicenter cross-sectional study. Neurology. 2004;63:919–21. · DOI · Paper page
  19. Österberg A, Boivie J, Thomas KA. Central pain in multiple sclerosis-prevalence and clinical characteristics. Eur J Pain. 2005;9:531–42. · DOI · Paper page
  20. Ehde DM, Osborne TL, Hanley MA, Jensen MP, Kraft GH. The scope and nature of pain in persons with multiple sclerosis. Mult Scler. 2006;12:629–38. · DOI
  21. Hadjimichael O, Kerns RD, Rizzo MA, Cutter G, Vollmer T. Persistent pain and uncomfortable sensations in persons with multiple sclerosis. Pain. 2007;127:35–41. · DOI · Paper page
  22. Piwko C, et al. Pain due to multiple sclerosis: analysis of the prevalence and economic burden in Canada. Pain Res Manag. 2007;12:259–65. · doi:10.1155/2007/128681
  23. Khan F, Pallant J. Chronic pain in multiple sclerosis: prevalence, characteristics and impact on quality of life in an Australian community cohort. J Pain. 2007;8:614–23. · DOI · Paper page
  24. Boneschi M, et al. Lifetime and actual prevalence of pain and headache in multiple sclerosis. Mult Scler. 2008;14:514–21. · DOI
  25. Douglas C, Wollin J, Windsor C. Illness and demographic correlates of chronic pain among a community-based sample of people with multiple sclerosis. Arch Phys Med Rehabil. 2008;89:1923–32. · DOI
  26. Hirsh AT, Turner AP, Ehde DM, Haselkorn JK. Prevalence and impact of pain in multiple sclerosis: physical and psychological contributors. Arch Phys Med Rehabil. 2009;90:646–51. · DOI
  27. Seixa D, Vasco Galhardo MJ, Guimarães J, Lima L. Pain in Portuguese patients with multiple sclerosis. Front Neurol. 2011;2:20.
  28. Aicher SA, Silverman MB, Winkler CW, Bebo Jr BF. Hyperalgesia in an animal model of multiple sclerosis. Pain. 2004;110:560–70. · DOI
  29. • Olechowski CJ, Truong JJ, Kerr BJ. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Pain. 2009;141(1–2):156–64. This article reports the dysregulation of glutamate transport function in abnormal pain behavior in response to persistent noxious stimulation in EAE mice. · DOI · Paper page
  30. • Thibault K, Calvino B, Pezet S. Characterisation of sensory abnormalities observed in an animal model of multiple sclerosis: a behavioural and pharmacological study. Eur J Pain. 2011;15(3):231.e1–231.e16. This article reports the clinical signs linked to pain in two models of EAE related to time-course changes in disease representing a model of sensory abnormalities in MS. Thibault et al. also reported pain relief with medications such as gabapentin, duloxetine, and tramadol. · DOI
  31. Waxman SG. Acquired channelopathies in nerve injury and MS. Neurology. 2001;56(12):1621–7. 26. · DOI
  32. Waxman SG, Dib-Hajj S, Cummins TR, Black JA. Sodium channels and pain. Proc Natl Acad Sci USA. 1999;96(14):7635–9. 6. · DOI · Paper page
  33. • Svendsen KB, Sørensen L, Jensen TS, Hansen HJ, Bach FW. MRI of the central nervous system in MS patients with and without pain. Eur J Pain. 2011;15(4):395–401. This study compares 13 subjects with MS with chronic pain and ten patients without pain. There was no association between chronic pain and the site of demyelinating lesions. · DOI
  34. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database of Syst Rev. 2007; Issue 4. Art. No.: CD005454 doi: 10.1002/14651858.CD005454.pub2 . · DOI · Paper page
  35. Solaro C, Brichetto G, Battaglia MA, Messmer Uccelli M, Mancardi GL. Antiepileptic medications in multiple sclerosis: adverse effects in a three-year follow-up study. Neurol Sci. 2005;25:307–10. · DOI
  36. Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia: use and side effects. Arch Neurol. 2001;19:129–36. · DOI · Paper page
  37. Shirzadi M, Alvestad S, Hovdal H, et al. Comparison of carbamazepine rash in multiple sclerosis and epilepsy. Acta Neurol Scand. 2012;125(1):60–3. · DOI
  38. Cianchetti C, Zuddas A, Randazzo AP, Perra L, Marrosu MG. Lamotrigine adjunctive therapy in painful phenomena in MS: preliminary observations. Neurology. 1999;53:433. · DOI
  39. Breuer B, et al. Randomized double-blind, placebo-controlled two period crossover pilot trial of lamotrigine in patients with central pain due to multiple sclerosis. Clin Ther. 2007;29:2022–30. · DOI
  40. Houtchens MK, Richert JR, Sami A, Rose JW. Open label gabapentin treatment for pain in multiple sclerosis. Mult Scler. 1997;3:250–3. · DOI
  41. Rossi S, et al. Effects of Levetiracetam on chronic pain in multiple sclerosis: results of a randomized placebo-controlled study. Eur J Neurol. 2009;16:360–6. · DOI
  42. Solaro C, Boemker M, Tanganelli P. Pregabalin for treating paroxysmal symptoms in multiple sclerosis: a pilot study. J Neurol. 2009;256:1773–4. · doi:10.1007/s00415-009-5203-6
  43. Solaro C, Tanganelli P. Acute delirium in patients with multiple sclerosis treated with pregabalin. Clin Neuropharmacol. 2009;32:236–7. · doi:10.1097/01.wnf.0000265979.03198.33
  44. Herman RM, D’Luzansky SC, Ippolito R. Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study. Clin J Pain. 1992;8:338–45. · doi:10.1097/00002508-199212000-00008
  45. Sadiq S, Poopatana C. Intrathecal basclofen and morphine in multiple sclerosis patients with severe pain and spasticity. J Neurol. 2007;254:1464–5. · doi:10.1007/s00415-007-0566-z
  46. Kalman S, Österbergn A, Sörensenn J, Boivie J, Bertler A. Morphine responsiveness in a group of well-defined multiple sclerosis patients: a study with i.v. morphine. Eur J Pain. 2002;6:69–80. · DOI
  47. Hooge JP, Redekop WK. Trigeminal neuralgia in multiple sclerosis. Neurology. 1995;45:1294–6. · DOI · Paper page
  48. • Mills RJ, Young CA, Smith ET. Central trigeminal involvement in multiple sclerosis using high-resolution MRI at 3T. Br J Radiol. 2010;83:493–8. The objective of this study was to determine the prevalence of trigeminal lesions using high-resolution MRI at 3T. Forty-seven patients with MS with a high prevalence of detectable trigeminal abnormalities were studied. MRI results did not correspond to trigeminal symptoms. · DOI
  49. •• Cruccu G, et al. Trigeminal neuralgia and pain related to multiple sclerosis. Pain. 2009;143:186–91. MRI scans were performed on 130 patients with MS: 50 with trigeminal neuralgia, 30 with trigeminal sensory disturbances other than trigeminal neuralgia and 50 without pain. Cruccu et al. concluded that the most likely cause of MS-related trigeminal neuralgia is a pontine plaque damaging the primary afferents. Nevertheless, in some patients a neurovascular contact may act as a concurring mechanism. · DOI · Paper page
  50. Hutchins LG, Harnsberger HR, Jacobs JM, Apfelbaum RI. Trigeminal neuralgia (tic douloureux): MR imaging assessment. Radiology. 1990;175:837–41. · doi:10.1148/radiology.175.3.2343134
  51. Lazar ML, Kirkpatrick JB. Trigeminal neuralgia and multiple sclerosis: demonstration of the plaque in an operative case. Neurosurgery. 1979;5:711–7. · DOI
  52. Da Silva CJ, Da Rocha AJ, Mendes MF, Maja Jr ACM, Braga FT, Tilbery CP. Trigeminal involvement in multiple sclerosis: magnetic resonance imaging findings with clinical correlation in a series of patients. Mult Scler. 2005;11:282–5. · DOI
  53. Nakashima I, Fujihara K, Kimpara T, Okita N, Takase S, Itoyama Y. Linear pontine trigeminal root lesions in multiple sclerosis: clinical and magnetic resonance imaging studies in 5 cases. Arch Neurol. 2001;58:101–4. · DOI
  54. Gass A, Kitchen N, MacManus DG, Moseley IF, Hennerici MG, Miller DH. Trigeminal neuralgia in patients with multiple sclerosis: lesion localization with magnetic resonance imaging. Neurology. 1997;49(4):1142–4. · DOI
  55. Meaney JFM, Watt JMG, Eldridge PR, Whitehouse GH, Wells JCD, Miles JB. Association between trigeminal neuralgia and multiple sclerosis: role of magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 1995;59:253–9. · DOI
  56. Broggi G, Ferroli P, Franzini A, Nazzi V, Farina L, La Mantia L, Milanese C. Operative findings and outcomes of microvascular decompression for trigeminal neuralgia in 35 patients affected by multiple sclerosis. Neurosurgery. 2004;55(4):830–8. discussion 838–9. · DOI
  57. Cruccu G, Leandri M, Feliciani M, Manfredi M. Idiopathic and symptomatic trigeminal pain. J Neurol Neurosurg Psychiatry. 1990;53(12):1034–42. · DOI
  58. Bergamaschi R, Romani A, Versino M, Callieco R, Gaspari D, Citterio A, Cosi V. Usefulness of trigeminal somatosensory evoked potentials to detect subclinical trigeminal impairment in multiple sclerosis patients. Acta Neurol Scand. 1994;89:412–4. · doi:10.1111/j.1600-0404.1994.tb02658.x
  59. Ramsaransing G, Zwanikken C, De Keyser J. Worsening of symptoms of multiple sclerosis associated with carbamazepine. BMJ. 2000;320:1113. · DOI
  60. Leandri M, et al. Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis. J Neurol. 2000;247:556–8. · DOI
  61. Solaro C, et al. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology. 1998;51:609–11. · DOI
  62. Solaro C, Uccelli MM, Brichetto G, Gasperini C, Mancardi GL. Topiramate relieves idiopathic and symptomatic trigeminal neuralgia. J Pain Symptom Manage. 2001;21:367–8. · doi:10.1016/s0885-3924(01)00275-5
  63. Solaro C, Uccelli MM, Uccelli A, Leandri M, Mancardi GL. Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. Eur Neurol. 2000;44:45–8. · DOI
  64. DMKG Study Group. Misoprostol in the treatment of trigeminal neuralgia associated with multiple sclerosis. J Neurol. 2003;250(542–545). · DOI
  65. Lunardi G, et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology. 1997;48:1714–7. · doi:10.1212/wnl.48.6.1714
  66. Khan OA. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology. 1998;51:611–4. · DOI · Paper page
  67. Zvartau-Hind M, Din MU, Gilan A, Lisak RP, Khan OA. Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology. 2000;55:1587–8. · DOI
  68. Reder AT, Arnason B. Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue. Neurology. 1995;45:1097–100. · DOI
  69. Linderoth B, Hakanson S. Paroxysmal facial pain in disseminated sclerosis treated by retrogasserian glycerol injection. Acta Neurol Scand. 1989;80:341–6. · doi:10.1111/j.1600-0404.1989.tb03890.x
  70. Kondziolka D, Lunsford LD, Bissonette DJ. Long-term results after glycerol rhizotomy for multiple sclerosis-related trigeminal neuralgia. Can J Neurol Sci. 1994;21:137–40. · doi:10.1017/s0317167100049076
  71. Berk C, Constantoyannis C, Honey CR. The treatment of trigeminal neuralgia in patients with multiple sclerosis using percutaneous radiofrequency rhizotomy. Can J Neurol Sci. 2003;30:220–3. · DOI
  72. Broggi G, Franzini A. Radiofrequency trigeminal rhizotomy in treatment of symptomatic non-neoplastic facial pain. J Neurosurg. 1982;57:483–6. · doi:10.3171/jns.1982.57.4.0483
  73. Rogers CL, et al. Gamma knife radiosurgery for trigeminal neuralgia associated with multiple sclerosis. J Neurosurg. 2002;97 Suppl 5:529–32. · DOI
  74. Huang E, et al. Gamma knife radiosurgery for treatment of trigeminal neuralgia in multiple sclerosis patients. Stereotact Funct Neurosurg. 2002;79:44–50. · doi:10.1159/000069503
  75. Broggi G, et al. Role of microvascular decompression in trigeminal neuralgia and multiple sclerosis. Lancet. 1999;354:1878–9. · DOI
  76. Al-Araji AH, Oger J. Reappraisal of Lhermitte’s sign in multiple sclerosis. Mult Scler. 2005;11:398–402. · DOI
  77. Minagar A, Sheremata WA. Glossopharyngeal neuralgia and MS. Neurology. 2000;54:1368–70. · DOI
  78. Solaro C, Uccelli MM, Guglieri P, Uccelli A, Mancardi GL. Gabapentin is effective in treating nocturnal painful spasms in multiple sclerosis. Mult Scler. 2000;6:192–3. · doi:10.1177/135245850000600310
  79. Solaro C, Tanganelli P. Tiagabine for treating painful tonic spasms in multiple sclerosis: a pilot study. J Neurol Neurosurg Psychiatry. 2004;75:341.
  80. Restivo DA, Tinazzi M, Patti F, Palmeri A, Maimone D. Botulinum toxin treatment of painful tonic spasms in multiple sclerosis. Neurology. 2003;61:719–20. · DOI
  81. Thompson AJ. Symptomatic treatment in multiple sclerosis. Curr Opin Neurol. 1998;11:305–9. · DOI
  82. Solaro C, Messmer Uccelli M. Management of pain in multiple sclerosis: a pharmacological approach. Nat Rev Neurol. 2011;7:519–27. · DOI
  83. Lienau FS, Füllgraf H, Moser A, Feuerstein TJ. Why do cannabinoids not show consistent effects as analgesic drugs in multiple sclerosis? Eur J Neurol. 2007;14:1162–9. · DOI
  84. Marrie RA, Horwitz RI, Cutter G, Tyry T, Vollmer T. Association between comorbidity and clinical characteristics of MS. Acta Neurol Scand. 2010;29:135–41.
  85. Haythornthwaite JA, Benrud-Larsen LM. Psychological aspects of neuropathic pain. Clin J Pain. 2000;16:S101–5. · DOI · Paper page
  86. Duarte R. In: Kanner R, editor. Pain management secrets, vol. 6. Philadelphia: Hanley & Belfus; 2003.
  87. • Saverino A, Solaro C. Pain in individuals with multiple sclerosis, knee prosthesis, and post-herpetic neuralgia: learning from focus group patients' experience. Clin J Pain. 2012;28(4):300–8. Unique, spontaneous descriptors, possibly disease-specific, emerged in various focus groups of subjects with MS and other diseases. All disease groups used descriptors not included in the McGill Pain Questionnaire, underlining the need for assessment measures of pain based on individual perception. · DOI
  88. Vermote R, Ketalaer P, Carlton H. Pain in multiple sclerosis patients: a prospective study using the McGill Pain Questionnaire. Clin Neurol Neurosurg. 1986;88:87–93. · DOI

Cited by

See all 177

Metadata

Authors
Solaro, C., Trabucco, E., & Messmer Uccelli, M.
Venue
Current Neurology and Neuroscience Reports
Published
2012-12-19
Volume
13
Issue
1
Pages
320-320
ISSN
  • 1528-4042 (ISSN-L)
  • 1534-6293
OpenAlex
W1970703427
Cited by
177
References
5
FWCI
4.78
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pain and Multiple Sclerosis: Pathophysiology and Treatment. https://app.cochat.ai/papers/10.1007/s11910-012-0320-5
The paper
Solaro, C., Trabucco, E., & Messmer Uccelli, M. (2013). Pain and Multiple Sclerosis: Pathophysiology and Treatment. Current Neurology and Neuroscience Reports. https://doi.org/10.1007/s11910-012-0320-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.